EGFR and non-small cell lung carcinoma: EGFR/MAP2K1/mTOR/TEAD1/YAP1 Could Mediate Invasive Tumor Phenotypes and Worse Prognoses of NSCLC Cohorts via a Mechanism Involving Both T-Cell Exclusion and Dysfunctional Phenotypes